The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Smirnov A.V.

Federal Research and Clinical Center for Specialized Medical Care and Medical Technologies

Brusina E.B.

Kemerovo State Medical University

Magaryll Yu.A.

Kemerovo State Medical University

Gordeeva L.A.

Federal Research Center for Coal and Coal Chemistry of the Siberian Branch of the Russian Academy of Sciences

Epidemiological analysis of prostate cancer risk factors

Authors:

Smirnov A.V., Brusina E.B., Magaryll Yu.A., Gordeeva L.A.

More about the authors

Journal: Russian Journal of Preventive Medicine. 2022;25(8): 75‑82

DOI: 10.17116/profmed20222508175

Read: 1594 times

Download PDF (RU)
Contact the author
Table of contents

EPIDEMIOLOGICAL ANALYSIS OF PROSTATE CANCER RISK FACTORS
EPIDEMIOLOGICAL ANALYSIS OF PROSTATE CANCER RISK FACTORS

To cite this article:

Smirnov AV, Brusina EB, Magaryll YuA, Gordeeva LA. Epidemiological analysis of prostate cancer risk factors. Russian Journal of Preventive Medicine. 2022;25(8):75‑82. (In Russ.)
https://doi.org/10.17116/profmed20222508175

 
Подписка 2026 Профилактическая медицина (Russian Journal of Preventive Medicine)
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Rationale for the use of non-linear statistical methods in the analysis of rela­tionships between risk factors and fatal events acco­rding to the data of long-term prospective obse­rvation in popu­lation of Russia and the United States of America. Russian Journal of Preventive Medi­cine. 2024;(11):34-39
Features of como­rbidity pathology in young people. Russian Journal of Preventive Medi­cine. 2024;(11):63-69
Gastric cancer: inci­dence, risk factors, screening. Russian Journal of Preventive Medi­cine. 2024;(12):135-139
Risk factors asso­ciated with myopic macu­lopathy in acquired myopia. Russian Annals of Ophthalmology. 2024;(5):35-45
Comparison of models for prediction of spontaneous preterm birth. Medi­cal Technologies. Asse­ssment and Choice. 2024;(4):10-19
Patterns of CAF expression in tumors of the geni­tourinary system. Russian Journal of Archive of Pathology. 2024;(6):28-35
Pote­ntial of specialized diet therapy in redu­cing toxic mani­festations in patients with meta­static castration-resistant prostate cancer with bone meta­stases during radionuclide therapy with radium chlo­ride [223Ra]. P.A. Herzen Journal of Onco­logy. 2024;(6):33-41
Stru­ctural and functional features of the main arte­ries of the brain and tumor necrosis factor-alpha in people with chro­nic non-infectious diseases. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):178-184
Features of primary and recu­rrent ischemic stroke in men aged 18—50 years. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12-2):65-74
Treatment of children with blunt spleen injury throughout 25-year period in Seva­stopol and the Repu­blic of Crimea. Piro­gov Russian Journal of Surgery. 2025;(2):67-76
Abstract:

OBJECTIVE

To study the effects of various factors on prostate cancer risk.

MATERIALS AND METHODS

An epidemiological analytical retrospective selective case-control study was performed. The study group included 305 subjects with prostate cancer (PCa), and the comparison group included 330 urological patients without PCa. We used the results of a direct open survey, data from outpatient (no. 025/y) and inpatient (no. 003/y) medical records of all participants, as well as the results of DNA genotyping of 200 patients.

RESULTS

The main risk factors for developing PCa were age over 50 years (OR 265.26; 95% CI 126.04—558.26; p<0.0001), hereditary background (OR 4.08; 95% CI 1.43—14.20; p=0.006) and the presence of (CAG)n AR gene polymorphism (OR 4.38; 95% CI 2.36—7.82; p<0.0001). The role of ethnicity, hypokinesia (p=0.002), smoking (p<0.001), alcohol consumption (p<0.001), fatty foods (p=0.03), and history of chronic prostatitis (p=0.014), and a high concentration of total testosterone (p<0.001) was studied.

CONCLUSION

The study results clarify the prostate cancer etiology and can be used to improve preventive measures in the region.

Keywords:

prostate cancer
risk factors
testosterone
dyslipidemia
genetic polymorphism

Authors:

Smirnov A.V.

Federal Research and Clinical Center for Specialized Medical Care and Medical Technologies

Brusina E.B.

Kemerovo State Medical University

Magaryll Yu.A.

Kemerovo State Medical University

Gordeeva L.A.

Federal Research Center for Coal and Coal Chemistry of the Siberian Branch of the Russian Academy of Sciences

Received:

04.05.2022

Accepted:

23.05.2022

Close metadata

References:

  1. Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Piñeros M, Znaor A, Bray F. Estimating the Global Cancer Incidence and Mortality in 2018: GLOBOCAN Sources and Methods. International Journal of Cancer. 2019;144(8):1941-1953. https://doi.org/10.1002/ijc.31937
  2. Teoh JYC, Hirai HW, Ho JMW, Chan FCH, Tsoi KKF, Ng CF. Global Incidence of Prostate Cancer in Developing and Developed Countries with Changing Age Structures. PLoS One. 2019;14(10):e0221775. https://doi.org/10.1371/journal.pone.0221775
  3. Pernar CH, Ebot EM, Wilson KM, Mucci LA. The Epidemiology of Prostate Cancer. Cold Spring Harbor Perspectives in Medicine. 2018;8(12):a030361. https://doi.org/10.1101/cshperspect.a030361
  4. Perez-Cornago A, Key TJ, Allen NE, Fensom GK, Bradbury KE, Martin RM, Travis RC. Prospective Investigation of Risk Factors for Prostate Cancer in the UK Biobank Cohort Study. British Journal of Cancer. 2017;117(10): 1562-1571. https://doi.org/10.1038/bjc.2017.312
  5. Meissner VH, Bittner R, Kron M, Schiele S, Schulwitz H, Gschwend JE, Herkommer K. Impact of a Changing Population Structure and Clustering of Cancer in Prostate Cancer Patients Depending on a First-Degree Family History. Urologia Internationalis. 2020;104(3-4):222-229.  https://doi.org/10.1159/000504789
  6. Brookman-May SD, Campi R, Henríquez JDS, Klatte T, Langenhuijsen JF, Brausi M, Linares-Espinós E, Volpe A, Marszalek M, Akdogan B, Roll C, Stief CG, Rodriguez-Faba O, Minervini A. Latest Evidence on the Impact of Smoking, Sports, and Sexual Activity as Modifiable Lifestyle Risk Factors for Prostate Cancer Incidence, Recurrence, and Progression: A Systematic Review of the Literature by the European Association of Urology Section of Oncological Urology (ESOU). European Urology Focus. 2019; 5(5):756-787.  https://doi.org/10.1016/j.euf.2018.02.007
  7. Hong S, Khil H, Lee DH, Keum N, Giovannucci EL. Alcohol Consumption and the Risk of Prostate Cancer: A Dose-Response Meta-Analysis. Nutrients. 2020;12(8):2188. https://doi.org/10.3390/nu12082188
  8. Capurso C, Vendemiale G. The Mediterranean Diet Reduces the Risk and Mortality of the Prostate Cancer: A Narrative Review. Frontiers in Nutrition. 2017;4:38.  https://doi.org/10.3389/fnut.2017.00038
  9. Downer MK, Batista JL, Mucci LA, Stampfer MJ, Epstein MM, Håkansson N, Wolk A, Johansson JE, Andrén O, Fall K, Andersson SO. Dairy Intake in Relation to Prostate Cancer Survival. International Journal of Cancer. 2017;140(9):2060-2069. https://doi.org/10.1002/ijc.30642
  10. Krstev S, Knutsson A. Occupational Risk Factors for Prostate Cancer: A Meta-analysis. Journal of Cancer Prevention. 2019;24(2):91-111.  https://doi.org/10.15430/JCP.2019.24.2.91
  11. Liu F, Wang J, Wu HL, Wang H, Wang JX, Zhou R, Zhu Z. Leisure Time Physical Activity and Risk of Prostate Cancer: a Dose-Response Meta-Analysis. Minerva Urologica e Nefrologica. 2018;70(2):152-161.  https://doi.org/10.23736/S0393-2249.17.02874-0
  12. Shephard RJ. Physical Activity and Prostate Cancer: An Updated Review. Sports Medicine. 2017;47(6):1055-1073. https://doi.org/10.1007/s40279-016-0648-0
  13. Jefferson M, Drake RR, Lilly M, Savage SJ, Tucker Price S, Hughes Halbert C. Co-morbidities in a Retrospective Cohort of Prostate Cancer Patients. Ethnicity and Disease. 2020;30(suppl 1):185-192.  https://doi.org/10.18865/ed.30.S1.185
  14. Gonzalez-Menendez P, Hevia D, Mayo JC, Sainz RM. The Dark Side of Glucose Transporters in Prostate Cancer: Are They a New Feature to Characterize Carcinomas? International Journal of Cancer. 2018;142(12):2414-2424. https://doi.org/10.1002/ijc.31165
  15. Junejo NN, AlKhateeb SS. BRCA2 Gene Mutation and Prostate Cancer Risk. Comprehensive Review and Update. Saudi Medical Journal. 2020; 41(1):9-17.  https://doi.org/10.15537/smj.2020.1.24759
  16. Tan JSJ, Ong KC, Ong DBL, Wu YS, Razack A, Kuppusamy S, Lim J, Rhodes A. Polymorphisms in the androgen receptor CAG repeat sequence are related to tumour stage but not to ERG or androgen receptor expression in Malaysian men with prostate cancer. The Malaysian Journal of Pathology. 2019;41(3):243-251. 
  17. Vasconcelos A, Santos T, Ravasco P, Neves PM. Dairy Products: Is There an Impact on Promotion of Prostate Cancer? A Review of the Literature. Frontiers in Nutrition. 2019;6:62.  https://doi.org/10.3389/fnut.2019.00062
  18. Barbalata CI, Tefas LR, Achim M, Tomuta I, Porfire AS. Statins in Risk-Reduction and Treatment of Cancer. World Journal of Clinical Oncology. 2020;11(8):573-588.  https://doi.org/10.5306/wjco.v11.i8.573
  19. Smirnov AV, Gruzdeva OV, Pomeshkin EV, Bragin-Maltsev AI. Dyslipidemia and Risk of Prostate Cancer in Patients with Urologic Diseases. Fundamental’naya i klinicheskaya medicina. 2022;7(1):42-52. (In Russ.). https://doi.org/10.23946/2500-0764-2022-7-1-42-52
  20. Watts EL, Perez-Cornago A, Knuppel A, Tsilidis KK, Key TJ, Travis RC. Prospective analyses of testosterone and sex hormone-binding globulin with the risk of 19 types of cancer in men and postmenopausal women in UK Biobank. International Journal of Cancer. 2021;149(3):573-584.  https://doi.org/10.1002/ijc.33555
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.